IMMUNE-MEDIATED ARTHRITIS

IMMUNE-MEDIATED ARTHRITIS was reported 381 times

IMMUNE-MEDIATED ARTHRITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Programmed Death Receptor-1 Blocking Antibody [EPC] 341 0.0035
1 Lymphocyte Activation Gene-3 Blocker [EPC] 1 0.0019
2 CTLA-4-directed Blocking Antibody [EPC] 80 0.0017
3 Programmed Death Ligand-1 Blocker [EPC] 19 0.0009
4 Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] 2 0.0003
5 Platinum-based Drug [EPC] 78 0.0003
6 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 2 0.0002
7 Microtubule Inhibitor [EPC] 32 0.0002
8 Stimulant Laxative [EPC] 2 0.0001
9 Antimalarial [EPC] 1 0.0001
10 Anti-anginal [EPC] 1 0.0001
11 Antiprotozoal [EPC] 1 0.0001
12 Topoisomerase Inhibitor [EPC] 6 0.0001
13 Parenteral Iron Replacement [EPC] 1 0.0001
14 Provitamin D2 Compound [EPC] 2 0.0001
15 Folate Analog Metabolic Inhibitor [EPC] 27 0.0001
16 Macrolide Antimicrobial [EPC] 3 0.0001
17 Orexin Receptor Antagonist [EPC] 1 0.0001
18 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
19 Serotonin-3 Receptor Antagonist [EPC] 6 0.0000
20 Bile Acid [EPC] 1 0.0000
21 Vascular Endothelial Growth Factor Inhibitor [EPC] 8 0.0000
22 Typical Antipsychotic [EPC] 1 0.0000
23 Alkaloid [EPC] 1 0.0000
24 Alkylating Drug [EPC] 9 0.0000
25 Nucleoside Metabolic Inhibitor [EPC] 9 0.0000
26 Kinase Inhibitor [EPC] 17 0.0000
27 Proton Pump Inhibitor [EPC] 17 0.0000
28 Histamine-2 Receptor Antagonist [EPC] 3 0.0000
29 alpha-Adrenergic Blocker [EPC] 3 0.0000
30 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
31 Purine Antimetabolite [EPC] 2 0.0000
32 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 2 0.0000
33 Factor Xa Inhibitor [EPC] 5 0.0000
34 Complement Inhibitor [EPC] 1 0.0000
35 Xanthine Oxidase Inhibitor [EPC] 3 0.0000
36 HMG-CoA Reductase Inhibitor [EPC] 6 0.0000
37 Vitamin B12 [EPC] 5 0.0000
38 Corticosteroid [EPC] 19 0.0000
39 Opioid Agonist [EPC] 4 0.0000
40 Thiazide Diuretic [EPC] 3 0.0000
41 Interleukin-6 Receptor Antagonist [EPC] 2 0.0000
42 Androgen Receptor Inhibitor [EPC] 1 0.0000
43 Vitamin D [EPC] 4 0.0000
44 Angiotensin 2 Receptor Blocker [EPC] 4 0.0000
45 Platelet Aggregation Inhibitor [EPC] 7 0.0000
46 Nonsteroidal Anti-inflammatory Drug [EPC] 16 0.0000
47 Vitamin C [EPC] 5 0.0000
48 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
49 Integrin Receptor Antagonist [EPC] 1 0.0000
50 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
51 Partial Opioid Agonist [EPC] 1 0.0000
52 Aminosalicylate [EPC] 1 0.0000
53 Dihydropyridine Calcium Channel Blocker [EPC] 3 0.0000
54 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
55 GLP-1 Receptor Agonist [EPC] 4 0.0000
56 Insulin Analog [EPC] 4 0.0000
57 Proteasome Inhibitor [EPC] 1 0.0000
58 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
59 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
60 Benzodiazepine [EPC] 5 0.0000
61 Osmotic Laxative [EPC] 2 0.0000
62 Azole Antifungal [EPC] 1 0.0000
63 Janus Kinase Inhibitor [EPC] 1 0.0000
64 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
65 Tumor Necrosis Factor Blocker [EPC] 6 0.0000
66 RANK Ligand Inhibitor [EPC] 1 0.0000
67 Atypical Antipsychotic [EPC] 2 0.0000
68 Loop Diuretic [EPC] 2 0.0000
69 beta-Adrenergic Blocker [EPC] 1 0.0000